Loading clinical trials...
Loading clinical trials...
Prospective Validation of Predictive Features of Paroxysmal Atrial Fibrillation: The Vancouver Stroke Program Pilot Study
Conditions
Locations
1
Canada
Vancouver Stroke Program
Vancouver, British Columbia, Canada
Start Date
November 19, 2015
Primary Completion Date
March 3, 2022
Completion Date
March 3, 2022
Last Updated
May 18, 2022
NCT05044208
NCT03609437
NCT05431972
NCT04604015
NCT05089435
NCT03107637
Lead Sponsor
University of British Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions